Mizuho lowered the firm’s price target on Align Technology (ALGN) to $250 from $295 and keeps an Outperform rating on the shares. The firm updated the company’s model post the results from competitor Angelalign. Angelalign continues to gain market share excluding China, but is still losing EBIT, the analyst tells investors in a research note. Mizuho is taking a more conservative stance on Mexico tariffs for Align.